ATE180496T1 - Peptid zur beschleunigung der wirkung des proteins-c mit thrombin - Google Patents

Peptid zur beschleunigung der wirkung des proteins-c mit thrombin

Info

Publication number
ATE180496T1
ATE180496T1 AT88900790T AT88900790T ATE180496T1 AT E180496 T1 ATE180496 T1 AT E180496T1 AT 88900790 T AT88900790 T AT 88900790T AT 88900790 T AT88900790 T AT 88900790T AT E180496 T1 ATE180496 T1 AT E180496T1
Authority
AT
Austria
Prior art keywords
peptide
thrombin
protein
accelerate
action
Prior art date
Application number
AT88900790T
Other languages
English (en)
Inventor
Shuji Yamamoto
Koji Suzuki
Original Assignee
Asahi Chemical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27547577&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE180496(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asahi Chemical Ind filed Critical Asahi Chemical Ind
Application granted granted Critical
Publication of ATE180496T1 publication Critical patent/ATE180496T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/7455—Thrombomodulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT88900790T 1987-01-08 1988-01-08 Peptid zur beschleunigung der wirkung des proteins-c mit thrombin ATE180496T1 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP106687 1987-01-08
JP106587 1987-01-08
JP14408187 1987-06-11
JP30587787 1987-12-04
JP30587687 1987-12-04
JP30587887 1987-12-04

Publications (1)

Publication Number Publication Date
ATE180496T1 true ATE180496T1 (de) 1999-06-15

Family

ID=27547577

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88900790T ATE180496T1 (de) 1987-01-08 1988-01-08 Peptid zur beschleunigung der wirkung des proteins-c mit thrombin

Country Status (5)

Country Link
US (1) US6034060A (de)
EP (4) EP0312598B1 (de)
AT (1) ATE180496T1 (de)
DE (1) DE3856335T2 (de)
WO (1) WO1988005053A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912207A (en) * 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof
US5202421A (en) * 1988-12-27 1993-04-13 Mochida Pharmaceutical Co., Ltd. Anticoagulant substance obtained from urine and process for the preparation thereof
US6063763A (en) * 1989-04-28 2000-05-16 Schering Aktiengesellschaft Protease-resistant thrombomodulin analogs
US5256770A (en) * 1990-04-09 1993-10-26 Schering Ag Oxidation resistant thrombomodulin analogs
CA2022713A1 (en) * 1989-08-11 1991-02-12 Nils U. Bang Human thrombomodulin derivatives
WO1991004276A1 (en) * 1989-09-25 1991-04-04 Asahi Kasei Kogyo Kabushiki Kaisha Isolated, physiologically active human thrombomodulin polypeptide
CA2065409C (en) * 1990-06-27 2002-05-14 Mochida Pharmaceutical Co., Ltd. Anticoagulant polypeptides
KR930008093B1 (ko) * 1990-08-03 1993-08-25 아사히가세이고오교 가부시끼가이샤 신규 폴리펩티드 및 이를 유효성분으로 하는 의약조성물
ATE249234T1 (de) * 1993-12-17 2003-09-15 Mochida Pharm Co Ltd Lösliches thrombomodulin enthaltende zubereitung
EP0763360B1 (de) * 1994-04-20 2005-02-16 Asahi Kasei Pharma Corporation Verwendung von thrombomodulin gegen lebererkrankungen
US5916874A (en) * 1994-04-20 1999-06-29 Asahi Kasei Kogyo Kabushiki Kaisha Method for treating liver injury
WO1998029453A1 (en) * 1996-12-27 1998-07-09 Mochida Pharmaceutical Co., Ltd. Cell membrane-directed drugs
WO1999018994A1 (en) 1997-10-15 1999-04-22 Asahi Kasei Kogyo Kabushiki Kaisha Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution
CA2332571A1 (en) * 1998-06-30 2000-01-06 Mochida Pharmaceutical Co., Ltd. Novel sugar chain-bonded thrombomodulin-like peptide
JP4340540B2 (ja) * 2002-01-18 2009-10-07 旭化成ファーマ株式会社 可溶性トロンボモジュリン高濃度含有製剤
JP2006096668A (ja) * 2002-11-08 2006-04-13 Ono Pharmaceut Co Ltd エラスターゼ阻害剤と血液凝固系および/または線溶系酵素阻害剤との組み合わせからなる医薬
MX2009003384A (es) * 2006-10-06 2009-04-08 Asahi Kasei Pharma Corp Agente terapeutico y/o de mejoramiento para la coagulacion intravascular diseminada.
CA2681294C (en) * 2007-03-23 2014-05-06 Asahi Kasei Pharma Corporation Method for producing high-purity soluble thrombomodulin
EP2120049A1 (de) 2008-05-14 2009-11-18 PAION Deutschland GmbH Lösliches Thrombomodulin als Biomarker bei Therapien mit Gerinnungshemmern
CN102481344A (zh) 2009-06-12 2012-05-30 帕昂德国有限公司 具有纤溶亢进的凝血病的治疗
JP2011178687A (ja) * 2010-02-26 2011-09-15 Kochi Univ 造血細胞移植に伴う疼痛の予防および/または治療剤
NZ602852A (en) 2010-04-30 2014-03-28 Asahi Kasei Pharma Corp Highly-purified soluble thrombomodulin and method for producing same
JP2013531651A (ja) 2010-06-14 2013-08-08 パイオン ドイチュラント ゲーエムベーハー 線溶亢進を伴う凝固障害の処置
PT2781221T (pt) 2011-11-15 2020-06-01 Asahi Kasei Pharma Corp Medicamento para tratamento e/ou melhoria de sepsia
DK2857037T3 (da) * 2012-05-31 2019-07-22 Univ Kinki Middel til forebyggelse og/eller behandling af perifere neuropatiske smerter forårsaget af anticancerlægemiddel
BR102017005783A2 (pt) * 2017-03-21 2018-10-02 Fund Butantan processo de obtenção de esculptina e seus fragmentos, esculptina recombinante e seus usos
WO2019074886A1 (en) 2017-10-09 2019-04-18 Terumo Bct Biotechnologies, Llc LYOPHILIZATION CONTAINER AND METHOD OF USE
CA3112679A1 (en) 2018-09-28 2020-04-02 Asahi Kasei Pharma Corporation Medicament for mitigating conditions and/or suppressing onset of peripheral neuropathy induced by anti-malignant tumor agent
BR112021007460A2 (pt) 2018-10-22 2021-11-03 Asahi Kasei Pharma Corp Medicamento para tratamento terapêutico e/ou melhora de um paciente com sepse
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
CN117534731B (zh) * 2021-09-24 2024-10-29 深圳市海伦海生物科技有限公司 一种抗凝血肽及其在抗凝血产品上的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60199819A (ja) * 1984-03-23 1985-10-09 Kowa Co トロンビン結合性物質およびその製法
WO1987000050A1 (fr) * 1985-06-28 1987-01-15 Asahi Kasei Kogyo Kabushiki Kaisha Nouvelle substance physiologiquement active limitant la coagulation du sang
JPH0689014B2 (ja) * 1986-01-21 1994-11-09 興和株式会社 トロンビン結合性物質およびその製法
US4912207A (en) * 1987-05-06 1990-03-27 Washington University DNA clone of human thrombomodulin and portions thereof
US5466668A (en) * 1989-04-28 1995-11-14 Schering Aktiengesellschaft Superior thrombomodulin analogs for pharmaceutical use
CA2065409C (en) * 1990-06-27 2002-05-14 Mochida Pharmaceutical Co., Ltd. Anticoagulant polypeptides
US5583102A (en) * 1993-12-03 1996-12-10 University Of Iowa Research Foundation Human thrombomodulin in wound healing

Also Published As

Publication number Publication date
EP0312598B1 (de) 1999-05-26
DE3856335D1 (de) 1999-07-01
EP0312598A4 (de) 1989-05-16
WO1988005053A1 (fr) 1988-07-14
EP0312598A1 (de) 1989-04-26
EP0816493A1 (de) 1998-01-07
US6034060A (en) 2000-03-07
EP0816494A1 (de) 1998-01-07
HK1002591A1 (en) 1998-09-04
JPH11236335A (ja) 1999-08-31
EP0816495A1 (de) 1998-01-07
DE3856335T2 (de) 2000-01-27

Similar Documents

Publication Publication Date Title
DE3856335D1 (de) Peptid zur beschleunigung der wirkung des proteins-c mit thrombin
ES8800266A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original
DE3880739D1 (de) Expression von menschlichem proapolipoprotein a-1.
DK0423302T3 (da) Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner
ES8307297A1 (es) Proceso para la produccion microbiana de interferon fibro- blasto humano
DE69839812D1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
ES8402351A1 (es) Procedimiento para producir interferon inmune humano.
KR880007734A (ko) 폴리펩타이드 유도체
DE69129865D1 (de) Osteogene peptide
ES2124685T3 (es) Variantes del inhibidor de la tripsina pancreatica bovina, su produccion y uso.
ES8802159A1 (es) Un procedimiento de producir un acido desoxirribonucleico (adn)que tiene o contiene una secuencia de base que codificaun polipeptido de factor de necrosis tumoral de humano
ES2052791T3 (es) Nuevos peptidos señal capaces de funcionar en levaduras, y expresion secretora de proteinas heterologas que utilizan los mismos.
PT666914E (pt) Nova proteina ligando da selectina p
IL84700A (en) Hybrid proteins,dnas coding therefor,hybrid vectors containing such dnas and hosts transformed therewith,the preparation of such hybrid proteins and pharmaceutical compositions containing them
SE8902507D0 (sv) Neutrofil-aktiverande faktor
DE59108947D1 (de) Neues menschliches, rekombinantes interferon gamma
EP0427863A4 (en) Dna coding for protein capable of combining with enhancer of alpha-fetoprotein gene
KR900702010A (ko) 루시페라아제, 그것을 코우드 하는 유전자 및 루시페라아제의 생산방법
DK595187A (da) Minactivin og fremgangsmaade til fremstilling deraf
ATE135407T1 (de) Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper
DE69330348D1 (de) Verwendung von Peptiden welche eine Immunantwort bewirken zur Herstellung von Medikamenten zur Induzierung der Immunsuppression.
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
DE68913802D1 (de) Thymosin und TNF-kodierende DNA.
MY103637A (en) Neutrophil-activating factor
ES2311472T3 (es) Nuevos genes de control del ciclo celular y proteinas codificadas por los mismos.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time